3.34
price down icon1.76%   -0.06
after-market After Hours: 3.34
loading
Cytek Biosciences Inc stock is traded at $3.34, with a volume of 3.05M. It is down -1.76% in the last 24 hours and down -12.11% over the past month. Cytek Biosciences Inc is a cell analysis solutions company advancing the next generation of cell analysis tools by leveraging novel technical approaches. Its core instruments, the Cytek Aurora and Northern Lights systems, are the first full-spectrum flow cytometers able to deliver high-resolution, high-content, and high-sensitivity cell analysis by utilizing the full spectrum of fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells. Its FSP platform addresses the inherent limitations of other technologies by providing a higher density of information with greater sensitivity, more flexibility, and increased efficiency, all at a lower cost for performance. Geographically, the company generates a majority of its revenue from the United States.
See More
Previous Close:
$3.40
Open:
$3.41
24h Volume:
3.05M
Relative Volume:
3.07
Market Cap:
$423.04M
Revenue:
$193.01M
Net Income/Loss:
$-12.15M
P/E Ratio:
-37.11
EPS:
-0.09
Net Cash Flow:
$454.00K
1W Performance:
+28.96%
1M Performance:
-12.11%
6M Performance:
-48.93%
1Y Performance:
-41.71%
1-Day Range:
Value
$3.26
$3.53
1-Week Range:
Value
$2.54
$3.53
52-Week Range:
Value
$2.37
$7.63

Cytek Biosciences Inc Stock (CTKB) Company Profile

Name
Name
Cytek Biosciences Inc
Name
Phone
(877) 922-9835
Name
Address
47215 LAKEVIEW BOULEVARD, FREMONT
Name
Employee
663
Name
Twitter
Name
Next Earnings Date
2024-11-05
Name
Latest SEC Filings
Name
CTKB's Discussions on Twitter

Compare CTKB with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Medical Devices icon
CTKB
Cytek Biosciences Inc
3.34 328.05M 193.01M -12.15M 454.00K -0.09
Medical Devices icon
ABT
Abbott Laboratories
133.94 231.14B 42.34B 13.50B 6.66B 7.71
Medical Devices icon
BSX
Boston Scientific Corp
102.83 154.60B 17.55B 2.03B 2.72B 1.37
Medical Devices icon
SYK
Stryker Corp
383.10 146.12B 23.22B 2.86B 3.58B 7.40
Medical Devices icon
MDT
Medtronic Plc
87.00 105.64B 33.54B 4.66B 5.19B 3.62
Medical Devices icon
EW
Edwards Lifesciences Corp
77.77 45.60B 5.54B 4.18B 623.10M 7.00

Cytek Biosciences Inc Stock (CTKB) Upgrades & Downgrades

Date Action Analyst Rating Change
May-09-25 Downgrade TD Cowen Buy → Hold
Jan-31-25 Downgrade Goldman Buy → Sell
Dec-14-23 Initiated Stephens Overweight
Jul-19-23 Initiated Raymond James Mkt Perform
Jan-06-22 Resumed Piper Sandler Overweight

Cytek Biosciences Inc Stock (CTKB) Latest News

pulisher
Jun 03, 2025

Bank of America Corp DE Boosts Holdings in Cytek Biosciences, Inc. (NASDAQ:CTKB) - Defense World

Jun 03, 2025
pulisher
Jun 02, 2025

Cytek Biosciences Leads Our Top 3 Penny Stock Selections - Yahoo Finance

Jun 02, 2025
pulisher
Jun 01, 2025

ProShare Advisors LLC Has $235,000 Stock Holdings in Cytek Biosciences, Inc. (NASDAQ:CTKB) - Defense World

Jun 01, 2025
pulisher
May 31, 2025

Cytek Biosciences, Inc. (NASDAQ:CTKB) Shares Sold by Jane Street Group LLC - Defense World

May 31, 2025
pulisher
May 31, 2025

Ameriprise Financial Inc. Has $1.62 Million Holdings in Cytek Biosciences, Inc. (NASDAQ:CTKB) - Defense World

May 31, 2025
pulisher
May 31, 2025

Cytek Biosciences, Inc. (CTKB) Elevates Cell Analysis with New Aurora Evo System - MSN

May 31, 2025
pulisher
May 30, 2025

Optimizing Lab Efficiency with Cytek's Aurora Evo Flow Cytometer - Lab Manager

May 30, 2025
pulisher
May 30, 2025

The Market Doesn't Like What It Sees From Cytek Biosciences, Inc.'s (NASDAQ:CTKB) Revenues Yet As Shares Tumble 31% - simplywall.st

May 30, 2025
pulisher
May 29, 2025

Where are the Opportunities in (CTKB) - news.stocktradersdaily.com

May 29, 2025
pulisher
May 29, 2025

Cytek® Biosciences Is Setting the New Standard for Full Spectrum Flow Cytometry with the New Cytek Aurora™ Evo Flow Cytometer - SINA HONG KONG LIMITED

May 29, 2025
pulisher
May 29, 2025

Cytek® Biosciences Is Setting the New Standard for Full - GlobeNewswire

May 29, 2025
pulisher
May 29, 2025

Cytek® Biosciences Is Setting the New Standard for Full Spectrum Flow Cytometry with the New Cytek Aurora™ Evo Flow Cytometer - GlobeNewswire Inc.

May 29, 2025
pulisher
May 29, 2025

Cytek Biosciences, Inc. (NASDAQ:CTKB) Shares Bought by Millennium Management LLC - Defense World

May 29, 2025
pulisher
May 29, 2025

Deutsche Bank AG Acquires 36,542 Shares of Cytek Biosciences, Inc. (NASDAQ:CTKB) - Defense World

May 29, 2025
pulisher
May 29, 2025

Cytek Biosciences (NASDAQ:CTKB) Given New $7.00 Price Target at Morgan Stanley - Defense World

May 29, 2025
pulisher
May 28, 2025

Cytek Biosciences to participate at the Goldman Sachs 46th Annual Global Healthcare Conference - GlobeNewswire

May 28, 2025
pulisher
May 28, 2025

Cytek Management Sets Key Investor Presentation at Goldman Sachs Healthcare Conference - Stock Titan

May 28, 2025
pulisher
May 28, 2025

Beyond The Numbers: 4 Analysts Discuss Cytek Biosciences Stock - Benzinga

May 28, 2025
pulisher
May 28, 2025

Cytek Biosciences (CTKB) Price Target Reduced by Morgan Stanley - GuruFocus

May 28, 2025
pulisher
May 28, 2025

Cytek Biosciences (CTKB) Price Target Reduced by Morgan Stanley | CTKB Stock News - GuruFocus

May 28, 2025
pulisher
May 28, 2025

Cytek Biosciences (CTKB) Price Target Revised by Morgan Stanley - GuruFocus

May 28, 2025
pulisher
May 28, 2025

Cytek Biosciences (CTKB) Price Target Revised by Morgan Stanley | CTKB Stock News - GuruFocus

May 28, 2025
pulisher
May 27, 2025

Cytek Biosciences to present at the 43rd Annual J.P. Morgan Healthcare Conference - The Globe and Mail

May 27, 2025
pulisher
May 26, 2025

Institutional investors may adopt severe steps after Cytek Biosciences, Inc.'s (NASDAQ:CTKB) latest 10% drop adds to a year losses - simplywall.st

May 26, 2025
pulisher
May 21, 2025

Cytek Biosciences stock hits 52-week low at $2.5 amid market challenges - Investing.com Canada

May 21, 2025
pulisher
May 20, 2025

BNP Paribas Financial Markets Takes Position in Cytek Biosciences, Inc. (NASDAQ:CTKB) - Defense World

May 20, 2025
pulisher
May 19, 2025

(CTKB) Pivots Trading Plans and Risk Controls - news.stocktradersdaily.com

May 19, 2025
pulisher
May 19, 2025

Cytek Biosciences, Inc. (NASDAQ:CTKB) Stake Raised by Northern Trust Corp - Defense World

May 19, 2025
pulisher
May 16, 2025

Cytek Biosciences (CTKB) Faces Price Target Cut Amid Weak Market Dynamics | CTKB Stock News - GuruFocus

May 16, 2025
pulisher
May 16, 2025

Price T Rowe Associates Inc. MD Boosts Stock Holdings in Cytek Biosciences, Inc. (NASDAQ:CTKB) - Defense World

May 16, 2025
pulisher
May 12, 2025

Goldman Sachs Maintains 'Sell' Rating on Cytek Biosciences (CTKB - GuruFocus

May 12, 2025
pulisher
May 10, 2025

Cytek Biosciences First Quarter 2025 Earnings: Misses Expectations - Yahoo

May 10, 2025
pulisher
May 10, 2025

Cytek Biosciences, Inc. (NASDAQ:CTKB) Q1 2025 Earnings Call Transcript - Insider Monkey

May 10, 2025
pulisher
May 10, 2025

Dimensional Fund Advisors LP Grows Position in Cytek Biosciences, Inc. (NASDAQ:CTKB) - Defense World

May 10, 2025
pulisher
May 10, 2025

Cytek Biosciences (CTKB) Downgraded to Hold as Challenges Persis - GuruFocus

May 10, 2025
pulisher
May 09, 2025

Cytek Biosciences, Inc. (CTKB) Reports Q1 Loss, Lags Revenue Estimates - MSN

May 09, 2025
pulisher
May 09, 2025

Cytek Biosciences: Earnings Call Reveals Mixed Fortunes - TipRanks

May 09, 2025
pulisher
May 09, 2025

Cytek Biosciences stock rating cut, price target drops to $4 By Investing.com - Investing.com Nigeria

May 09, 2025
pulisher
May 09, 2025

Cytek Biosciences stock rating cut, price target drops to $4 - Investing.com

May 09, 2025
pulisher
May 09, 2025

TD Cowen Downgrades Cytek Biosciences to Hold From Buy, Adjusts Price Target to $4 From $7 - marketscreener.com

May 09, 2025
pulisher
May 09, 2025

Cytek Biosciences (CTKB) Downgraded to Hold as Challenges Persist | CTKB Stock News - GuruFocus

May 09, 2025
pulisher
May 09, 2025

Cytek Biosciences Faces Revenue Challenges and Market Uncertainty, Downgraded to Hold - TipRanks

May 09, 2025
pulisher
May 09, 2025

Cytek Biosciences Inc (CTKB) Q1 2025 Earnings Call Highlights: Navigating Growth Amid Market ... By GuruFocus - Investing.com Canada

May 09, 2025
pulisher
May 09, 2025

Cytek Biosciences Reports First Quarter 2025 Financial Results - GlobeNewswire

May 09, 2025
pulisher
May 09, 2025

Cytek Biosciences Reports Q1 2025 Financial Results - TipRanks

May 09, 2025
pulisher
May 08, 2025

Earnings call transcript: Cytek Biosciences misses Q1 2025 earnings forecasts - Investing.com

May 08, 2025
pulisher
May 08, 2025

Cytek Biosciences, Inc. SEC 10-Q Report - TradingView

May 08, 2025
pulisher
May 08, 2025

Cytek Biosciences (CTKB) Reports Q1 Revenue Below Expectations | CTKB Stock News - GuruFocus

May 08, 2025

Cytek Biosciences Inc Stock (CTKB) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$317.16
price down icon 0.64%
medical_devices STE
$243.58
price up icon 0.61%
medical_devices SNN
$30.30
price up icon 3.52%
$71.55
price up icon 0.59%
$85.74
price up icon 0.15%
medical_devices EW
$77.77
price down icon 0.10%
Cap:     |  Volume (24h):